The what, why and how of hypertensive heart disease

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Left ventricular hypertrophy is now recognised to be an important risk factor associated with such adverse cardiovascular events as myocardial infarction, heart failure, stroke and sudden cardiac death. This is true for the general population and those with uncomplicated hypertension. Herein the what, why and how of hypertensive heart disease (HHD) is reviewed: what is it, why does a structural remodelling of the myocardium occur and how can it be prevented on the one hand or regressed on the other. Clinical and experimental studies are presented to address each of these issues.

Original languageEnglish (US)
Pages (from-to)665-675
Number of pages11
JournalJournal of Human Hypertension
Volume8
Issue number9
StatePublished - 1994
Externally publishedYes

Fingerprint

Sudden Cardiac Death
Left Ventricular Hypertrophy
Heart Diseases
Myocardium
Heart Failure
Stroke
Myocardial Infarction
Hypertension
Population
Clinical Studies

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

The what, why and how of hypertensive heart disease. / Weber, Karl.

In: Journal of Human Hypertension, Vol. 8, No. 9, 1994, p. 665-675.

Research output: Contribution to journalReview article

@article{1cd01eee868d49aaaf53503bc320dc0c,
title = "The what, why and how of hypertensive heart disease",
abstract = "Left ventricular hypertrophy is now recognised to be an important risk factor associated with such adverse cardiovascular events as myocardial infarction, heart failure, stroke and sudden cardiac death. This is true for the general population and those with uncomplicated hypertension. Herein the what, why and how of hypertensive heart disease (HHD) is reviewed: what is it, why does a structural remodelling of the myocardium occur and how can it be prevented on the one hand or regressed on the other. Clinical and experimental studies are presented to address each of these issues.",
author = "Karl Weber",
year = "1994",
language = "English (US)",
volume = "8",
pages = "665--675",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - The what, why and how of hypertensive heart disease

AU - Weber, Karl

PY - 1994

Y1 - 1994

N2 - Left ventricular hypertrophy is now recognised to be an important risk factor associated with such adverse cardiovascular events as myocardial infarction, heart failure, stroke and sudden cardiac death. This is true for the general population and those with uncomplicated hypertension. Herein the what, why and how of hypertensive heart disease (HHD) is reviewed: what is it, why does a structural remodelling of the myocardium occur and how can it be prevented on the one hand or regressed on the other. Clinical and experimental studies are presented to address each of these issues.

AB - Left ventricular hypertrophy is now recognised to be an important risk factor associated with such adverse cardiovascular events as myocardial infarction, heart failure, stroke and sudden cardiac death. This is true for the general population and those with uncomplicated hypertension. Herein the what, why and how of hypertensive heart disease (HHD) is reviewed: what is it, why does a structural remodelling of the myocardium occur and how can it be prevented on the one hand or regressed on the other. Clinical and experimental studies are presented to address each of these issues.

UR - http://www.scopus.com/inward/record.url?scp=0027990878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027990878&partnerID=8YFLogxK

M3 - Review article

VL - 8

SP - 665

EP - 675

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 9

ER -